{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:26:28Z","timestamp":1788618388240,"version":"build-2803163510"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The gut microbiome is a critical regulator of host health, but how it mediates the therapeutic effects of drugs targeting neurodegenerative diseases like diabetic cognitive impairment (DCI) is unclear. Here, we investigated whether the neuroprotective effects of the GLP-1 agonist semaglutide (SE) are linked to its modulation of the gut-brain axis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used an integrative multi-omics approach in a mouse model of DCI. We combined fecal shotgun metagenomics and targeted bile acid profiling with cerebral proteomics and metabolomics to characterize the gut-brain crosstalk following a 12-week SE treatment. Animal behavior, neuronal survival and synaptic integrity were assessed to confirm therapeutic efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      SE treatment reversed cognitive deficits, rescued hippocampal neuronal loss, and restored synaptic integrity in diabetic mice. At the ecosystem level, metagenomics revealed that SE treatment profoundly remodeled the gut microbiota, enhancing microbial \u03b1-diversity, enriched beneficial genera (\n                      <jats:italic>Bacteroides<\/jats:italic>\n                      ,\n                      <jats:italic>Barnesiella<\/jats:italic>\n                      ), and depleted the pro-inflammatory genus\n                      <jats:italic>Desulfovibrio<\/jats:italic>\n                      . This microbial shift was associated with normalized fecal and cerebral bile acid profiles. Mechanistically, our analysis implicated a dysregulated sphingolipid pathway in the DCI brain, characterized by the upregulation of the transporter ATP-binding cassette transporter A2 (ABCA2) and the enzymes sphingosine-1-phosphate phosphatase 1 (SGPP1) and ceramide synthase 2 (CERS2). SE treatment dynamically modulated this pathway: it downregulated ABCA2 in a potentially weight-independent manner and SGPP1 in a weight-dependent fashion, linked to the normalization of cerebral bile acid profiles. In contrast, CERS2, a robust marker of disease severity, was not altered by SE.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study uncovers a novel \u201cgut microbiota\u2013bile acid\u2013sphingolipid\u201d axis in DCI and suggests that SE acts via a dual mechanism. It drives a weight-dependent restoration of the gut-brain axis, normalizing microbial and bile acid profiles to regulate SGPP1, while also exerting weight-independent effects, potentially through direct modulation of targets like ABCA2. This work highlights the gut microbiome as a key component in the therapeutic action of SE and reveals the multifaceted nature of its neuroprotective effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1705784","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:33:26Z","timestamp":1774506806000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Multi-omics profiling implicates gut microbiota-sphingolipid interplay in the neuroprotective effects of semaglutide on diabetic cognitive impairment"],"prefix":"10.3389","volume":"17","author":[{"given":"Liqin","family":"Qi","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Fujian Institute of Endocrinology, Fujian Medical University Union Hospital, Fuzhou","place":["Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fujian Medical University Union Hospital, Fuzhou","place":["Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou","place":["Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Fujian Institute of Endocrinology, Fujian Medical University Union Hospital, Fuzhou","place":["Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinchen","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Pharmacy, Fujian Medical University, Fuzhou","place":["Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglan","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Fujian Institute of Endocrinology, Fujian Medical University Union Hospital, Fuzhou","place":["Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihui","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Fujian Institute of Endocrinology, Fujian Medical University Union Hospital, Fuzhou","place":["Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Fujian Institute of Endocrinology, Fujian Medical University Union Hospital, Fuzhou","place":["Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Fujian Institute of Endocrinology, Fujian Medical University Union Hospital, Fuzhou","place":["Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Pharmacy, Fujian Medical University, Fuzhou","place":["Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Fujian Institute of Endocrinology, Fujian Medical University Union Hospital, Fuzhou","place":["Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13568-023-01520-3","article-title":"The gut microbiota pathway mechanisms of diabetes.","volume":"13","author":"Bajinka","year":"2023","journal-title":"AMB Express"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100138","DOI":"10.1016\/j.xcrm.2020.100138","article-title":"Metabolic network analysis reveals altered bile acid synthesis and metabolism in Alzheimer\u2019s disease.","volume":"1","author":"Baloni","year":"2020","journal-title":"Cell Rep. Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-physiol-031620-093815","article-title":"Ceramides in metabolism: Key lipotoxic players.","volume":"83","author":"Chaurasia","year":"2021","journal-title":"Annu. Rev. Physiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"134186","DOI":"10.1016\/j.ijbiomac.2024.134186","article-title":"Fucoidan prevents diabetic cognitive dysfunction via promoting TET2-mediated active DNA demethylation in high-fat diet induced diabetic mice.","volume":"278","author":"Chen","year":"2024","journal-title":"Int. J. Biol. Macromol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2379566","DOI":"10.1080\/19490976.2024.2379566","article-title":"Bacteroides fragilis alleviates necrotizing enterocolitis through restoring bile acid metabolism balance using bile salt hydrolase and inhibiting FXR-NLRP3 signaling pathway.","volume":"16","author":"Chen","year":"2024","journal-title":"Gut Microbes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1080\/1028415X.2023.2301165","article-title":"Refined diet consumption increases neuroinflammatory signalling through bile acid dysmetabolism.","volume":"27","author":"Connell","year":"2024","journal-title":"Nutr. Neurosci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2174\/156720501209151019105834","article-title":"The ATP-binding cassette transporter-2 (ABCA2) overexpression modulates sphingosine levels and transcription of the amyloid precursor protein (APP) gene.","volume":"12","author":"Davis","year":"2015","journal-title":"Curr. Alzheimer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-024-10142-w","article-title":"Semaglutide attenuates anxious and depressive-like behaviors and reverses the cognitive impairment in a type 2 diabetes mellitus mouse model via the microbiota-gut-brain axis.","volume":"19","author":"de Paiva","year":"2024","journal-title":"J. Neuroimmune Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.2147\/DMSO.S375559","article-title":"The relationship between the blood-brain-barrier and the central effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors.","volume":"15","author":"Dong","year":"2022","journal-title":"Diabetes Metab. Syndr. Obes"},{"key":"B10","doi-asserted-by":"publisher","first-page":"177305","DOI":"10.1016\/j.ejphar.2025.177305","article-title":"The GLP-1 agonist semaglutide ameliorates cognitive regression in P301S tauopathy mice model via autophagy\/ACE2\/SIRT1\/FOXO1-Mediated Microglia Polarization.","volume":"991","author":"Elbadawy","year":"2025","journal-title":"Eur. J. Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e17891","DOI":"10.7717\/peerj.17891","article-title":"Effects of semaglutide on gut microbiota, cognitive function and inflammation in obese mice.","volume":"12","author":"Feng","year":"2024","journal-title":"PeerJ"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e133429","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways.","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"},{"key":"B13","doi-asserted-by":"publisher","first-page":"eaay6690","DOI":"10.1126\/science.aay6690","article-title":"The genetic architecture of the human cerebral cortex.","volume":"367","author":"Grasby","year":"2020","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbalip.2010.05.003","article-title":"Roles for dysfunctional sphingolipid metabolism in Alzheimer\u2019s disease neuropathogenesis.","volume":"1801","author":"Haughey","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"B15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/bpa.12433","article-title":"Mango leaf extract improves central pathology and cognitive impairment in a type 2 diabetes mouse model.","volume":"27","author":"Infante-Garcia","year":"2017","journal-title":"Brain Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1007\/s12035-018-1286-3","article-title":"The cross-talk between sphingolipids and insulin-like growth factor signaling: Significance for aging and neurodegeneration.","volume":"56","author":"J\u00ea\u015bko","year":"2019","journal-title":"Mol. Neurobiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"101162","DOI":"10.1016\/j.plipres.2022.101162","article-title":"Sphingolipid control of cognitive functions in health and disease.","volume":"86","author":"Kalinichenko","year":"2022","journal-title":"Prog. Lipid Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1099\/ijs.0.64517-0","article-title":"Bacteroides barnesiae sp. nov., Bacteroides salanitronis sp. nov. and Bacteroides gallinarum sp. nov., isolated from chicken caecum.","volume":"56","author":"Lan","year":"2006","journal-title":"Int. J. Syst. Evol. Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"122744","DOI":"10.1016\/j.lfs.2024.122744","article-title":"Gut dysbiosis contributes to SCFAs reduction-associated adipose tissue macrophage polarization in gestational diabetes mellitus.","volume":"350","author":"Li","year":"2024","journal-title":"Life Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1039\/c9fo00213h","article-title":"A holistic view of gallic acid-induced attenuation in colitis based on microbiome-metabolomics analysis.","volume":"10","author":"Li","year":"2019","journal-title":"Food Funct"},{"key":"B21","volume-title":"Committee IDFDAtes: IDF Diabetes Atlas.","author":"Magliano","year":"2021"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s11095-022-03302-1","article-title":"Therapeutic potential of semaglutide, a newer GLP-1 receptor agonist, in abating obesity, non-alcoholic steatohepatitis and neurodegenerative diseases: A narrative review.","volume":"39","author":"Mahapatra","year":"2022","journal-title":"Pharm. Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/S0140-6736(12)60360-2","article-title":"Diabetes and cognitive dysfunction.","volume":"379","author":"McCrimmon","year":"2012","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1243132","DOI":"10.3389\/fendo.2023.1243132","article-title":"Sphingolipid metabolism in brain insulin resistance and neurological diseases.","volume":"14","author":"Mei","year":"2023","journal-title":"Front. Endocrinol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e00615","DOI":"10.1016\/j.neurot.2025.e00615","article-title":"Gut microbiota mediates semaglutide attenuation of diabetes-associated cognitive decline.","volume":"22","author":"Qi","year":"2025","journal-title":"Neurotherapeutics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes.","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"101543","DOI":"10.1016\/j.xcrm.2024.101543","article-title":"Increased intestinal bile acid absorption contributes to age-related cognitive impairment.","volume":"5","author":"Ren","year":"2024","journal-title":"Cell Rep. Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41573-021-00262-w","article-title":"Engineering islets from stem cells for advanced therapies of diabetes.","volume":"20","author":"Siehler","year":"2021","journal-title":"Nat. Rev. Drug Discov"},{"key":"B29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00592-017-0970-5","article-title":"Cognitive impairment and dementia: A new emerging complication of type 2 diabetes-The diabetologist\u2019s perspective.","volume":"54","author":"Sim\u00f3","year":"2017","journal-title":"Acta Diabetol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1002482","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jbior.2018.09.013","article-title":"Sphingolipids in neurodegeneration (with focus on ceramide and S1P).","volume":"70","author":"Wang","year":"2018","journal-title":"Adv. Biol. Regul"},{"key":"B32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3892\/ijmm.2021.5052","article-title":"Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazole-kindled mice.","volume":"48","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"109716","DOI":"10.1016\/j.neuropharm.2023.109716","article-title":"Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer\u2019s disease via the GLP-1R\/SIRT1\/GLUT4 pathway.","volume":"240","author":"Wang","year":"2023","journal-title":"Neuropharmacology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fnagi.2017.00106","article-title":"The impact of microbiota-gut-brain axis on diabetic cognition impairment.","volume":"9","author":"Xu","year":"2017","journal-title":"Front. Aging Neurosci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3892\/ijmm.2025.5497","article-title":"Transcriptomics and proteomics characterizing the antioxidant mechanisms of semaglutide in diabetic mice with cognitive impairment.","volume":"55","author":"Yang","year":"2025","journal-title":"Int. J. Mol. Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.18632\/aging.101978","article-title":"Abnormal gut microbiota composition contributes to cognitive dysfunction in streptozotocin-induced diabetic mice.","volume":"11","author":"Yu","year":"2019","journal-title":"Aging"},{"key":"B37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/JPD-181503","article-title":"Semaglutide is neuroprotective and reduces \u03b1-synuclein levels in the chronic MPTP mouse model of Parkinson\u2019s disease.","volume":"9","author":"Zhang","year":"2019","journal-title":"J. Parkinsons Dis"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1705784\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:33:28Z","timestamp":1774506808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1705784\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":37,"alternative-id":["10.3389\/fmicb.2026.1705784"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1705784","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"article-number":"1705784"}}